Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak

Carregando...
Imagem de Miniatura
Citações na Scopus
96
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
MUSSO, Didier
BOSSIN, Herve
MALLET, Henri Pierre
BESNARD, Marianne
BROULT, Julien
BAUDOUIN, Laure
GHAWCHE, Frederic
LANTERI, Marion C.
Citação
LANCET INFECTIOUS DISEASES, v.18, n.5, p.E172-E182, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The Zika virus crisis exemplified the risk associated with emerging pathogens and was a reminder that preparedness for the worst-case scenario, although challenging, is needed. Herein, we review all data reported during the unexpected emergence of Zika virus in French Polynesia in late 2013. We focus on the new findings reported during this outbreak, especially the first description of severe neurological complications in adults and the retrospective description of CNS malformations in neonates, the isolation of Zika virus in semen, the potential for blood-transfusion transmission, mother-to-child transmission, and the development of new diagnostic assays. We describe the effect of this outbreak on health systems, the implementation of vector-borne control strategies, and the line of communication used to alert the international community of the new risk associated with Zika virus. This outbreak highlighted the need for careful monitoring of all unexpected events that occur during an emergence, to implement surveillance and research programmes in parallel to management of cases, and to be prepared to the worst-case scenario.
Palavras-chave
Referências
  1. AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053, DOI 10.4269/ajtmh.1981.30.1053
  2. Abraham Alon, 2011, J Clin Neuromuscul Dis, V12, P113, DOI 10.1097/CND.0b013e318209ef9a
  3. American Association of Blood Banks, 2016, AM ASS BLOOD BANKS A
  4. Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
  5. Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
  6. Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
  7. Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
  8. Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
  9. Barber B, 2009, AUST FAM PHYSICIAN, V38, P586
  10. Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
  11. Baronti Cecile, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00500-14
  12. Baud D, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5319
  13. Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
  14. Bel M., 2007, ZIKA VIRUS PRELIMINA
  15. Belkin J.N., 1962, MOSQUITOES S PACIFIC, V1
  16. Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
  17. Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
  18. Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
  19. Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
  20. Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
  21. Bourtzis K, 2014, ACTA TROP
  22. Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
  23. Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
  24. Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
  25. Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
  26. Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
  27. Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
  28. Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
  29. Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
  30. Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
  31. Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
  32. Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
  33. Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
  34. Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
  35. Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
  36. Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
  37. Cressey D, 2015, NATURE, V517, P255, DOI 10.1038/517255a
  38. D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
  39. Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
  40. de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
  41. Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
  42. DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
  43. Dickens BL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw103
  44. Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
  45. dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
  46. Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
  47. Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
  48. Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
  49. Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
  50. ECDC, 2016, ZIK VIR SAF SUBST HU
  51. Esack A, 1999, W INDIAN MED J, V48, P36
  52. European Centre for Disease Prevention and Control, 2014, MON CURR THREATS ECD
  53. European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
  54. Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
  55. FDA, 2016, REV REC RED RISK ZIK
  56. Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
  57. Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
  58. Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
  59. Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
  60. Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480
  61. Gubler DJ, 2007, FIELDS VIROLOGY, P1155
  62. Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
  63. Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
  64. Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
  65. Hapairai LK, 2013, J MED ENTOMOL, V50, P965, DOI 10.1603/ME12246
  66. Hapairai LK, 2013, J MED ENTOMOL, V50, P731, DOI 10.1603/ME12270
  67. Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
  68. Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
  69. Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
  70. Kessler CM, 2016, CLIN ADV HEMATOL ONC, V14, P677
  71. Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
  72. Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
  73. Kutsuna S, 2017, J INFECT CHEMOTHER, V23, P114, DOI 10.1016/j.jiac.2016.08.003
  74. Laigret J, 1967, Bull Soc Pathol Exot Filiales, V60, P339
  75. Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
  76. Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
  77. Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455
  78. Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
  79. Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
  80. Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
  81. Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
  82. Mallet H-P, 2016, B EPIDEMIOLOGIQUE HE, V2016, P20
  83. Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
  84. Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
  85. Maria FS, 2016, TRANSFUSION, V56, p11A
  86. Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
  87. Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
  88. Mercer DR, 2012, J MED ENTOMOL, V49, P51, DOI 10.1603/ME11087
  89. Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
  90. Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
  91. Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
  92. Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
  93. Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI 10.2807/1560-7917.ES2014.19.14.20761
  94. Musso D, 2017, ISBT SCI SERIES, V12, P254
  95. Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
  96. Musso D, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0551-8
  97. Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
  98. Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
  99. Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
  100. Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
  101. Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
  102. Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
  103. Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
  104. Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
  105. Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
  106. Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018
  107. Oehler E., 2014, Eurosurveillance, V19, P20720
  108. Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
  109. Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
  110. Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mbio.01239-16, 10.1128/mBio.01239-16]
  111. Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
  112. Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
  113. Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
  114. Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
  115. Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
  116. Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
  117. Roth Adam, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2008.130696
  118. Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
  119. Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
  120. Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
  121. Singh Narendra, 2005, Pac Health Dialog, V12, P111
  122. Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
  123. Trosemeier J-H, 2016, GENOME ANNOUNC, V4
  124. Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
  125. Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
  126. Cao-Lormeau VM, 2016, EMERG INFECT DIS, V22, P913, DOI 10.3201/eid2205.150547
  127. Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
  128. Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
  129. Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
  130. WHO, 2016, MAINT SAF AD BLOOD S
  131. Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
  132. Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
  133. World Health Organization, 2017, SIT REP ZIK VIR MICR
  134. World Health Organization (WHO), 2009, DENG GUID DIAGN TREA
  135. Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
  136. Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192